Safety of TNF-α inhibitors during IBD pregnancy: a systematic review

Sa1226 TNF-Alpha Inhibitor Therapy and Fetal Risk: A Systematic Literature Review

(2015) Renee M. Marchioni et al.   GASTROENTEROLOGY

865 PIANO: A 1000 Patient Prospective Registry of Pregnancy Outcomes in Women With IBD Exposed to Immunomodulators and Biologic Therapy

(2015) Uma Mahadevan et al.   GASTROENTEROLOGY

Safety of Thiopurines and Anti-TNF-α Drugs During Pregnancy in Patients With Inflammatory Bowel Disease

(2013) M J Casanova et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

P401 Pregnancy outcomes in women with inflammatory bowel disease exposed to infliximab

(2013) Y. Snoeckx et al.   Journal of Crohns & Colitis

P605 Adalimumab (ADA) and infliximab (IFX) therapy during pregnancy in IBD: a prospective assessment of outcome, safety and cord blood levels

(2013) S. Traussnigg et al.   Journal of Crohns & Colitis

P580 Biologic therapy in pregnancy and inflammatory bowel disease: a prospective 7 year study: clinical outcome

(2013) F. Habal   Journal of Crohns & Colitis

Serious Infection and Mortality in Patients With Crohn's Disease: More Than 5 Years of Follow-Up in the TREAT™ Registry

(2012) Gary R Lichtenstein et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Placental Transfer of Anti–Tumor Necrosis Factor Agents in Pregnant Patients With Inflammatory Bowel Disease

(2012) Uma Mahadevan et al.   Clinical Gastroenterology and Hepatology

Effects of Discontinuing Anti–Tumor Necrosis Factor Therapy During Pregnancy on the Course of Inflammatory Bowel Disease and Neonatal Exposure

(2012) Zuzana Zelinkova et al.   Clinical Gastroenterology and Hepatology

Transplacental Transfer of Immunosuppressants and Biologics Used for the Treatment of Inflammatory Bowel Disease

(2012) Maria Chaparro et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

P370 Pregnancy and newborn outcome of mothers with inflammatory bowel disease exposed to anti-TNFα therapy during pregnancy: Three-centre study

(2012) N. Machkova et al.   Journal of Crohns & Colitis

Can TNF inhibitors be administered during the third trimester?

(2012) Ole Haagen Nielsen et al.   Nature Reviews Gastroenterology & Hepatology

Is safety infliximab during pregnancy in patients with inflammatory bowel disease?

(2012) Federico Argüelles-Arias et al.   REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS

High intra-uterine exposure to infliximab following maternal anti-TNF treatment during pregnancy

(2011) Z. Zelinkova et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy

(2011) Fabian Schnitzler et al.   INFLAMMATORY BOWEL DISEASES

Intentional infliximab use during pregnancy for severe steroid-refractory ulcerative colitis

(2011) Annalisa Aratari et al.   Journal of Crohns & Colitis

Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from Japan

(2011) Makoto Naganuma et al.   Journal of Crohns & Colitis

Therapeutic infliximab drug level in a child born to a woman with ulcerative colitis treated until gestation week 31

(2011) Casper Steenholdt et al.   Journal of Crohns & Colitis

Use of biological molecules in the treatment of inflammatory bowel disease

(2011) O. H. Nielsen et al.   JOURNAL OF INTERNAL MEDICINE

VACTERL/VATER Association

(2011) Benjamin D Solomon   Orphanet Journal of Rare Diseases

Review article: use of antitumour necrosis factor therapy in inflammatory bowel disease during pregnancy and conception

(2010) S. O'DONNELL et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD With the European Crohn's and Colitis Organisation: Pregnancy and Pediatrics

(2010) Uma Mahadevan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Inflammatory bowel disease and pregnancy: report of two cases treated with infliximab and a review of the literature

(2010) Lucianna Motta Correia et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

A safety assessment of tumor necrosis factor antagonists during pregnancy

(2010) Vanessa C Osting et al.   Expert Opinion On Drug Safety

W1318 Certolizumab Treatment of Linear IgA Dermatosis in a Pregnant Crohn's Colitis Patient: A Case Study and Review of the Literature

(2010) Sarah A. Steinberg et al.   GASTROENTEROLOGY

764 One Year Newborn Outcomes Among Offspring of Women With Inflammatory Bowel Disease: The PIANO Registry

(2010) Uma Mahadevan et al.   GASTROENTEROLOGY

Inadvertent Conception During Concomitant Treatment with Infliximab and Methotrexate in a Patient with Crohnʼs Disease: Is the Game Worth the Candle?

(2010) E. Angelucci et al.   INFLAMMATORY BOWEL DISEASES

Successful use of infliximab for perianal Crohnʼs disease in pregnancy

(2010) Maria Chaparro et al.   INFLAMMATORY BOWEL DISEASES

Legionella pneumophila pneumonia in a pregnant woman treated with anti-TNF-α antibodies for Crohn's disease: A case report

(2010) G. Epping et al.   Journal of Crohns & Colitis

Case Report: Fatal case of disseminated BCG infection in an infant born to a mother taking infliximab for Crohn's Disease

(2010) Kuldeep Cheent et al.   Journal of Crohns & Colitis

Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: A population-based study from western Hungary 1977–2008

(2010) Peter Laszlo Lakatos et al.   Journal of Crohns & Colitis

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: A case–control study

(2010) Tamás Molnár et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Tumour necrosis factor antagonists and inflammatory bowel diseases: a national practice survey

(2009) A. OUSSALAH et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Biologic therapy and pregnancy outcomes in women with rheumatic diseases

(2009) Evelyne Vinet et al.   ARTHRITIS AND RHEUMATISM

A 24-Year-Old Pregnant Woman With Inflammatory Bowel Disease

(2009) Jason K. Hou et al.   Clinical Gastroenterology and Hepatology

Adalimumab Level in Breast Milk of a Nursing Mother

(2009) Shomron Ben–Horin et al.   Clinical Gastroenterology and Hepatology

Certolizumab use in pregnancy

(2009) A Oussalah et al.   GUT

Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics

(2009) Gil Y. Melmed   INFLAMMATORY BOWEL DISEASES

Safety of Adalimumab in Crohnʼs Disease During Pregnancy: Case Report and Review of the Literature

(2009) Matthias Jürgens et al.   INFLAMMATORY BOWEL DISEASES

Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding

(2009) Javier P. Gisbert   INFLAMMATORY BOWEL DISEASES

Absence of Infliximab in Infants and Breast Milk From Nursing Mothers Receiving Therapy for Crohnʼs Disease Before and After Delivery

(2009) Sunanda Kane et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Do Tumor Necrosis Factor Inhibitors Cause Malformations in Humans?

(2009) G. KOREN et al.   JOURNAL OF RHEUMATOLOGY

Was Risk Properly Assessed in Carter, et al's Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy?

(2009) E. E. WINGER et al.   JOURNAL OF RHEUMATOLOGY

A Safety Assessment of Tumor Necrosis Factor Antagonists During Pregnancy: A Review of the Food and Drug Administration Database

(2009) J. D. CARTER et al.   JOURNAL OF RHEUMATOLOGY

Placental Transport of Immunoglobulins: A Clinical Review for Gastroenterologists Who Prescribe Therapeutic Monoclonal Antibodies to Women During Conception and Pregnancy

(2008) Sunanda V Kane et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Is infliximab safe to use while breastfeeding?

(2008) Joel Z Stengel et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Safe use of infliximab for the treatment of fistulizing Crohnʼs disease during pregnancy within 3 months of conception

(2007) Erika Angelucci et al.   INFLAMMATORY BOWEL DISEASES